Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first and largest cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network (HVTN). Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
Funded by the National Institutes of Health since 2000, HVTN is the worlds largest publicly funded multi-disciplinary international collaboration facilitating the development of vaccines to prevent HIV/AIDS. The HVTN conducts all phases of clinical trials, from evaluating experimental vaccines for safety and immunogenicity to testing vaccine efficacy. In 2020, the COVID-19 Prevention Network (CoVPN) was constituted, a collaboration between four US government-sponsored clinical trials/research networks: HVTN, HIV Prevention Trials Network (HPTN), AIDS Clinical Trials Group (ACTG), and the Infectious Disease Clinical Research Consortium (IDCRC). The HVTN Leadership Operations Center, based at Fred Hutch, was designated the operations center for CoVPN vaccine trials. Since its inception, the CoVPN has seen implementation of 5 large 30,000-person efficacy trials of COVID-19 vaccines, as well as additional observational studies and clinical trials of COVID-19 vaccines at more than 120 US and international sites. The Statistical and Data Management Center (SDMC) of both the HVTN and CoVPN, also based at Fred Hutch, provides statistical design and analysis support, and houses datasets pertaining to all HVTN and CoVPN vaccine trials.
The Biostatistics, Bioinformatics and Epidemiology (BBE) Program within the Vaccine and Infectious Disease Division of Fred Hutch is seeking a Senior Staff Scientist to serve as Lead Statistician in support of HVTN and CoVPN research and publications, in collaboration with other members of the BBE program and scientists within the HVTN and CoVPN research community.
The Senior Staff Scientist will contribute to the HVTN and CoVPN research agenda through independent and collaborative research, initially focusing on CoVPN research as a critical priority.
The incumbent may perform some or all of the following responsibilities:
Provide statistical leadership in the design, analyses and dissemination of HVTN and CoVPN research studies.
Author and lead analyses based on protocol-specific and cross-protocol data, and contribute to the preparation of manuscripts.
Mentor masters-level statisticians as necessary.
Contribute statistical methods development arising from problems in vaccine statistical science.
Maintain current knowledge of and contribute to advancements in the vaccine prevention research field through participation in professional organizations, scientific conferences, reading industry journals, and publication of manuscripts.
Perform other tasks as required.
A successful candidate will have a Ph.D. or equivalent in biostatistics, epidemiology, or applied statistics.
Minimum of 3-5 years of related working experience.
Experience working with geographically diverse academic/industrial collaborative groups within a clinical research environment.
Experience in late-phase clinical trials, and/or in population-science epidemiological observational studies.
Experience in statistical methods for late-phase clinical trials and/or epidemiological observational studies.
Interest in or experience with the analysis of immunology and virology data types integrated with clinical data.
Prior knowledge of clinical trials, and infectious diseases (e.g., SARS-CoV-2, polio, TB, HIV, etc.).
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations. As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.